Section Questions Answers

Similar documents
Applying clinical guidelines treating and managing CKD

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

Office Management of Reduced GFR Practical advice for the management of CKD

CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral

Chronic Kidney Disease

Primary Care Approach to Management of CKD

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Transforming Diabetes Care

Chronic Kidney Disease

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

Outpatient Management of Chronic Kidney Disease for the Internist

CHRONIC RENAL FAILURE: WHAT THE PRIMARY CARE CAN OFFER. The annual conference of the Lebanese Society of Family Medicine October 2017 Dr Hiba AZAR

Supplement: Summary of Recommendation Statements CHAPTER 1: DEFINITION AND CLASSIFICATION OF CKD

Faculty/Presenter Disclosure

Session 9: Optimizing the Management of Patients with Chronic Kidney Disease Learning Objectives

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care

Dr.Nahid Osman Ahmed 1

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Kidney Disease, Hypertension and Cardiovascular Risk

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Renal Replacement Therapy - Indication and Follow up

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH

Clinical Pearls in Renal Medicine

8/12/2016. Diabetes Management Across the Spectrum of Kidney Function. Andrew Bzowyckyj. Learning Objectives. Ashley Crowl

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Identifying and Managing Chronic Kidney Disease: A Practical Approach

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George

ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour

Stages of Chronic Kidney Disease (CKD)

Chronic Kidney Disease: Optimal and Coordinated Management

Diabetic Kidney Disease in the Primary Care Clinic


Chronic kidney disease : The role of the Pharmacist

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

6/10/2014. Chronic Kidney Disease - General management and standard of care. Management of CKD according to stage (KDOQI 2002)

VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease

CKD FOR PRIMARY CARE MINNESOTA ACADEMY OF PHYSICIANS 2017 HEATHER ANN MUSTER, MD MS

Updates in Chronic Kidney Disease Management. Delphine S. Tuot, MDCM, MAS Associate Professor of Medicine UCSF-ZSFG

Predicting and changing the future for people with CKD

Supplementary Appendix

Chronic Kidney Disease - An Overview

Long-Term Care Updates

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

egfr > 50 (n = 13,916)

Chronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US

KEEP 2.0 Annual Data Report Chapter Five

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

Acute renal failure Definition and detection

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Management of early chronic kidney disease

Chronic kidney disease

Case Studies: Renal and Urologic Impairments Workshop

Systolic Blood Pressure Intervention Trial (SPRINT)

The National Quality Standards for Chronic Kidney Disease

NUTRITION CONSIDERATIONS FOR PATIENTS WITH DIABETIC NEPHROPATHY

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

Cardiovascular Pharmacotherapy in Special Population: Cardio-Nephrology

Chronic Renal Failure Followed by Acute Renal Failure

Clinical Approach to the Patient At-Risk for Kidney Disease: Rationale for Testing for Serum Creatinine and Albuminuria

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Disclosures. Topics. Staging and GFR. K-DOQI Staging of Chronic Kidney Disease. Definition of Chronic Kidney Disease. Chronic Kidney Disease

Tread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease

Chronic Kidney Disease in Primary Care

Diabetes and Hypertension

CKD and risk management : NICE guideline

Renal Failure Update in Treatment Part 1. DANIEL WALTON, DO, FACP,FACOI,FASN PARTNER, AKDHC, LLC PHOENIX AZ (602)

Diabetic Nephropathy Larry Lehrner, Ph.D.,M.D.

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis

Case Study: Chronic Kidney Disease

Managing Chronic Kidney Disease: Reducing Risk for CKD Progression

The future is here. It s just not widely distributed yet. William Gibson

Nephrology referral - Does my patient need it? Disclosure

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47

Chapter 2 Chronic Kidney Disease (CKD) in Cancer Patients

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Figure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis).

Acute Kidney Injury. I. David Weiner, M.D. Division of Nephrology, Hypertension and Transplantation University of Florida and NF/SGVHS

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Chronic kidney disease-what can you do and when to refer?

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Understanding. Your Kidneys. Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016

Transcription:

Section Questions Answers Guide to CKD Screening and Evaluation -Alec Otteman, MD Delaying Progression - Paul Drawz, MD, MHS, MS 1. Modifiable risk factors for CKD include: a. Diabetes b. Hypertension c. History of AKI d. Frequent NSAID use e. All of the above 2. NKF recommends the following calculator be used to estimate GFR for CKD staging: a. CKD-EPI b. MDRD c. Cockroft-Gault 1. Target blood pressure in non-dialysis CKD with a albuminto-creatinine ratio of <30mg/g should be: a. 120/80mmHg b. 140/90mmHg c. 150/90mmHg d. 130/80mmHg 2. A 55 year-old Caucasian-American man, with a history of type 2 diabetes (15 years), hypertension (3 years) dyslipidemia (5 years) and cardiovascular disease (myocardial infarction 3 years ago). He was recently diagnosed with CKD. His most recent labs reveal an egfr of 45 ml/min/1.73m 2 and an ACR of 38 mg/g. Which of the following should be avoided? E. All of the above Rationale: Diabetes, hypertension, history of AKI, and frequent NSAID use can all damage the kidneys and are risk factors for CKD A.. All of the above Rationale: CKD-EPI is less biased than MDRD particularly at high GFRs and performs equally, or better compared to the MDRD equation in various age groups and all BMI groups (except those with a BMI <20) and is calibrated for the IDMS standardized creatinine available from all labs B. 140/90mmHg Rationale: Comparison of Guideline Recommendations for CKD Blood Pressure Targets among reliable sources, including JAMA2014 and KDIGO2012, contain similar recommendations as less than 140/90 mm Hg in CKD E. A and C Rationale: ACE and ARBs used in combination have been shown to increase adverse events, particularly impaired kidney function and hyperkalemia. NSAIDs

A Primary Care Approach to Managing CKD Complications- Sandra Taler, MD Kidney Disease and Heart Failure: Where Medication Efficacy and Safety Collide - Wendy St. Peter, PharmD, FCCP, BCPS a. ACE and ARB in combination b. Daily low-dose aspirin c. NSAIDs d. Statins e. A and C 1. Vitamin D3 is the preferred vitamin D form to achieve normal serum vitamin D levels a. True b. False 2. Which CKD Stage to most of the complications of Kidney Failure start? a. Stage A b. Stage 1 c. Stage 3 d. Stage 5 Which of the following is NOT a reason for diuretic resistance in patients with AHF and CKD: a. Low salt diet b. High urinary protein c. Patient non-adherence d. Braking phenomenon: distal tubule cells hypertrophy over time and become sodium avid. When may NSAIDs be appropriate in patients with AHF and CKD? a. Anytime b. Never have been shown to cause kidney damage and increase CKD progression. Statins are indicated based on KDIGO guidelines and a daily low-dose aspirin is not contraindicated in CKD. True Rationale: Vitamin D3 is less expensive and better absorbed than Vitamin D2 C. Stage 3 Rationale: Stage A is not part of CKD staging. A. Low salt diet Rationale: Low salt diet will improve efficacy of diuretic B. Never Rationale: NSAIDS are always to be avoided due to potential risks of sodium retention, fluid overload, acute kidney injury, and hyperkalemia.

c. If the patient rates pain greater than 6 on a scale of 1-10. d. The patient has some at home. Renal Replacement Therapy: Options and Choices -Marc Weber, MD The Patient Provider Intersection: A CKD Story -Matt Rongstad- Patient and Sara Ruiz, Renal RD 1. Renal replacement therapy should be considered if the patient is experiencing: a. Hyperkalemia b. Metabolic acidosis c. Fluid overload 2. Types of Hemodialysis access include: a. Fistula b. Graft c. Catheter What did Matt (our patient representative) offer as some suggestions to health care professionals providing care to patients with chronic kidney disease? a. Individualize care to patients along the spectrum of very engaged to overwhelmed. b. Be proactive in helping patients weigh risks and benefits of treatment options c. Provide education for prevention strategies of dialysis and CKD progression Which of the following statements accurately describes Matt s experience with the healthcare system: a. Insurance questions were easy to figure out. Rationale: Dialysis can help regulate potassium, acid/base balance and fluid. When the kidneys can no longer balance, renal replacement therapy should be considered Rationale: Fistulas, grafts, and catheters are all established types of hemodialysis access. Rationale: There are ways healthcare professionals can approach patients with CKD to engage them as much as possible and optimize patient-related outcomes. B. He needed to use multiple pharmacies. Rationale: The healthcare system, including pharmacy providers, is

The Dialysis Unit: Behind Closed Doors - Andrew Kummer, MD MPH Kidney Transplantation -John Silkensen, MD b. He needed to use multiple pharmacies. c. It was clear to him which doctors were managing which conditions and who to go to for questions. d. His healthcare systems communicated well between each other. Benefits of preserving residual kidney function in dialysis patients include: a. Less dietary restriction b. Better quality of life c. Better survival It is not necessary to avoid nephrotoxins, such as NSAIDs, if patient is on dialysis and has residual kidney function. a. T b. F 1. Which of the following Is not absolute contraindications to renal transplant? a. Active substance abuse b. Active malignancy c. Life expectancy less than 2 years d. GFR <20mL/min 2. A patient with progressive CKD is considering a kidney transplant. Which one of the following statements is correct? tough to navigate for patients. Health care professionals need to consider challenges and complexity of the system itself as care is provided. S. All of the above Rationale: residual kidney function contributes to removal of potential uremic toxins, helps regulate fluid and electrolyte imbalance, and may enhance nutritional status and QOL. B. False As indicated above, residual kidney should be maintained if possible, thus the importance of avoiding nephrotoxins as part of this strategy. D. GFR <20mL/min Rationale: GFR of <20mL/min is when patients should be referred for a consultation about renal transplant. All other answer choices are contraindications to transplant Rationale: All of the statements are

Through the Lens of a Primary Care Professional - David Macomber, MD, PhD a. CKD patients can be referred to a transplant center when their GFR is < 20 ml/min/1.73m 2 b. Pre-emptive and live kidney transplants are associated with better graft survival c. Most common cause of kidney transplant loss is death with a functional transplant 1. When should a patient be referred to Nephrology? a. egfr 60 or below b. Presence of proteinuria/ microalbuminuria or microscopic hematuria irrespective of the egfr c. Strong family history 2. The most important nutrition goal/s for patients with CKD include: a. Limit Na, decrease HTN b. Reduce Protein c. Glycemic Control/Weight correct regarding transplant Rationale: According to KDIGO 2012, patients should be referred to Nephrology when egfr is at or below 60, there is a presence of proteinuria/ microalbuminuria or microscopic hematuria irrespective of the egfr, or if the patient has a strong family history. Rationale: There are several important nutrition goals for patients with CKD, including limiting Sodium, decreasing hypertension (if elevated), reduce protein intake, and maintaining a proper weight.